On Campus

From pigs, the possibility of replacement tissue

With donor organs unavailable for most of the 80,000 people awaiting transplants in the United States, scientists are working to overcome the two biggest hurdles to xenotransplantation—immune rejection and infection. A Massachusetts company, Immerge BioTherapeutics, in collaboration with researchers around the country, has eliminated a gene in a cloned “knockout” pig that produces a key enzyme in the rejection process. The company has also identified swine that do not produce porcine endogenous retrovirus, which has been found to infect human cells in vitro.“The waiting list for transplants continues to grow,” Julia L. Greenstein, Ph.D.,...

Read more...

An advocate for access, for all

An advocate for access, for all

As a child Tomas Lagerwall paid a visit to a “cripple center” in his native Sweden. “I remember...

Read more...

In medicine, a spiritual crisis

In medicine, a spiritual crisis

Medical science has, in the last century and a half, permitted miracles unimaginable in the day of...

Read more...

Giving names to the dead in the wake of 9/11

Giving names to the dead in the wake of 9/11

As the Office of the Chief Medical Examiner in New York City began processing the victims of 9/11,...

Read more...


 
 
Download on the Apple App Store